Restricted accessOtherFirst published online 2001-2
• Death Caused by Unregulated “Internet Drug”/ • More Problems with Herbals and OTCs/ • Fluoxetine ADRs: Postmarketing Reporting/ • Recurrent Supraventricular Tachycardia in a Pediatric Patient Receiving Albuterol/ • Fatal Arrhythmias in Hyperkalemic Patients Given Lidocaine
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
HainerM.I.Fatal Hepatorenal failure associated with hydrazine sulfate. Ann Intern Med.2000; 133: 877–80.
2.
PiesR.Adverse neuropsychiatric reactions to herbal and over-the-counter “antidepressants.”J Clin Psychiatry.2000; 61:815–20
3.
Palop-LarreaV.Metrorrhagia and ginseng [letter]. Ann Pharmacother.2000; 34: 1347–8.
4.
MusaM.N., StaneliusJ.M.Adverse events with fluoxetine: Postmarketing compared with premarketing clinical trials [letter]. J Clin Psychiatry.2000; 61: 874
5.
ZajeckaJ.Changes in adverse events reported by patients during 6 months of fluoxetine therapy. J Clin Psychiatry.1999; 60: 389–94.
6.
DuaneM., ChandranL., MorelliP.J.Recurrent supraventricular tachycardia as a complication of nebulized albuterol treatment. Clin Pediatr.2000; 39: 673–7.
7.
McLeanS.A., PaulI.D., SpectorP.S.Lidocaine-induced conduction disturbance in patients with systemic hyperkalemia. Ann Emerg Med.2000; 36: 615–18.
